Alpha1 Antitrypsin Deficiency the undiagnosed killer

Written by Mark Egly

September 1, 2022

Today Alpha1 Antitrypsin is the #1 Genetic Killer of Adults because of a failure to test for this very treatable condition!

Alpha 1 Antitrypsin is an orphan disease. The USA identifies an orphan disease as a condition that affects less than 200,000 people.

Soon Alpha1 Antitrypsin Deficiency will no longer be identified as an orphan disease because we will locate millions of others when proper testing methods become part of the standard of care! Estimates are that less than 10,000 people have been diagnosed with Alpha1 Antitrypsin Deficiency under current testing guidelines and parameters. The prevalence of this genetic situation is more likely to be 15 million people affected in the United States alone.